Author:
Ahmed Lamiaa A.,EL-Maraghy Shohda A.,Rizk Sherine M.
Publisher
Springer Science and Business Media LLC
Reference52 articles.
1. Dollery, C. Cyclophosphamide. In: Dollery C., editor. Therapeutic Drugs, Churchill Livingstone, Edinburg. p. 349–353 (1999).
2. Goldberg, M. A., Antin, J. H., Guinan, E. C. & Rappeport, J. M. Cyclophosphamide cardiotoxicity: an analysis of doing as a risk factor. Blood. 68, 1114–1118 (1986).
3. Fraiser, L. H., Kanekal, S. & Kehrer, J. P. Cyclophosphamide toxicity. Characterising and avoiding the problem. Drugs. 42(5), 781–795 (1991).
4. Liu, F. et al. The cyclophosphamide metabolite, acrolein, induces cytoskeletal changes and oxidative stress in Sertoli cells. Mol. Biol. Rep. 39(1), 493–500 (2012).
5. Saba, et al. Ellagic acid attenuates bleomycin and cyclophosphamide-induced pulmonary toxicity in Wistar rats. Food Chem. Toxicol. 58, 210–219 (2013).
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献